Related content

Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients

By Lu Jian-Feng   Claret Laurent   Sutjandra Liviawati   Kuchimanchi Mita   Melara Rebeca   Bruno René   Sun Yu-Nien  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1151-1158

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography

By          

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 965-968

Spandidos Publications

Access to resources Recommend Favorite

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

By Berruti Alfredo   Generali Daniele   Bertaglia Valentina   Brizzi Maria Pia   Mele Teresa   Dogliotti Luigi   Bruzzi Paolo   Bottini Alberto  

Journal of the National Cancer Institute Monographs, Vol. 2011, Iss. 43, 2011-10 ,pp. : 142-146

Oxford University Press

Access to resources Recommend Favorite

A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy

By Bal C. S.   Kumar Ajay   Chandra Prem   Dwivedi S. N.   Pant G. S.  

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1067-1072

Informa Healthcare

Access to resources Recommend Favorite

Variation in survival of adult patients with thyroid cancer in Europe

By Teppo L.   Hakulinen T.  

European Journal of Cancer, Vol. 34, Iss. 14, 1998-12 ,pp. : 2248-2252

Elsevier

Access to resources Recommend Favorite